Canadian Association of Radiologists Journal
Volume 60, Issue 3 , Pages 133-142 , June 2009

MRA: Current Applications in Body Vascular Imaging

  • Viesha A. Ciura, MD

      Affiliations

    • Department of Diagnostic Imaging, Foothills Medical Centre, Calgary, Alberta, Canada
    • ,
  • Mark J. Lee, MD

      Affiliations

    • Department of Diagnostic Imaging, Foothills Medical Centre, Calgary, Alberta, Canada
    • Corresponding Author InformationAddress for correspondence: Mark J. Lee, MD, Department of Diagnostic Imaging Foothills Medical Centre, 1403 29 Street NW, Calgary, Alberta T2N 2T9, Canada.
    • ,
  • Drew C. Schemmer, MD

      Affiliations

    • Department of Diagnostic Imaging, Foothills Medical Centre, Calgary, Alberta, Canada
    • Department of Diagnostic Imaging, Royal Victoria Hospital, Barrie, Ontario, Canada

References 

  1. Green D, Parker D. CTA and MRA: visualization without catheterization. Semin Ultrasound CT MR. 2003;24:185–191
  2. Goldman JP. New techniques and applications for magnetic resonance angiography. Mt Sinai J Med. 2003;70:375–385
  3. Rowe VL, Tucker SW. Advances in vascular imaging. Surg Clin North Am. 2004;84:1189–1202v
  4. Wedeen VJ, Meuli RA, Edelman RR, et al. Projective imaging of pulsatile flow with magnetic resonance. Science. 1985;230:946–948
  5. Leiner T. Magnetic resonance angiography of abdominal and lower extremity vasculature. Top Magn Reson Imaging. 2005;16:21–66
  6. Korosec FR, Frayne R, Grist TM, et al. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med. 1996;36:345–351
  7. Swan JS, Carroll TJ, Kennell TW, et al. Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology. 2002;225:43–52
  8. Ayuso JR, de Caralt TM, Pages M, et al. MRA is useful as a follow-up technique after endovascular repair of aortic aneurysms with nitinol endoprostheses. J Magn Reson Imaging. 2004;20:803–810
  9. Poitevin LA. Thoraco-cervico-brachial confined spaces an anatomic study. Ann Chir Main. 1988;7:5–13
  10. Demondion X, Bacqueville E, Paul C, et al. Thoracic outlet: assessment with MR imaging in asymptomatic and symptomatic populations. Radiology. 2003;227:461–468
  11. Hagspiel KD, Spinosa DJ, Angle JF, et al. Diagnosis of vascular compression at the thoracic outlet using gadolinium-enhanced high-resolution ultrafast MR angiography in abduction and adduction. Cardiovasc Intervent Radiol. 2000;23:152–154
  12. Dymarkowski S, Bosmans H, Marchal G, et al. Three-dimensional MR angiography in the evaluation of thoracic outlet syndrome. AJR Am J Roentgenol. 1999;173:1005–1008
  13. Lang E. Arteriography of thoracic outlet syndrome. In:  Baum S editors. Abrams angiography: vascular and interventional radiology. Boston (MA): Little, Brown Medical Division; 1997;p. 995–1010
  14. Leung DA, McKinnon GC, Davis CP, Pfammatter T, Krestin GP, Debatin JF. Breath-hold, contrast-enhanced, three-dimensional MR angiography. Radiology. 1996;200:569–571
  15. Charon JP, Milne W, Sheppard DG, et al. Evaluation of MR angiographic technique in the assessment of thoracic outlet syndrome. Clin Radiol. 2004;59:588–595
  16. Ouwendijk R, de Vries M, Pattynama PM, et al. Imaging peripheral arterial disease: a randomized controlled trial comparing contrast-enhanced MR angiography and multi-detector row CT angiography. Radiology. 2005;236:1094–1103
  17. Nelemans PJ, Leiner T, de Vet HC, et al. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Radiology. 2000;217:105–114
  18. Portugaller HR, Schoellnast H, Hausegger KA, et al. Multislice spiral CT angiography in peripheral arterial occlusive disease: a valuable tool in detecting significant arterial lumen narrowing?. Eur Radiol. 2004;14:1681–1687
  19. Leiner T, Kessels AG, Nelemans PJ, et al. Peripheral arterial disease: comparison of color duplex US and contrast-enhanced MR angiography for diagnosis. Radiology. 2005;235:699–708
  20. Goldblatt H, Lynch J, Hanzal RF, et al. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–379
  21. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431–442
  22. Leiner T, de Haan MW, Nelemans PJ, et al. Contemporary imaging techniques for the diagnosis of renal artery stenosis. Eur Radiol. 2005;15:2219–2229
  23. Zhang H, Prince MR. Renal MR angiography. Magn Reson Imaging Clin N Am. 2004;12:487–503vi
  24. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135:401–411
  25. Balzer JO, Loewe C, Davis K, et al. Safety of contrast-enhanced MR angiography employing gadobutrol 1.0 M as contrast material. Eur Radiol. 2003;13:2067–2074
  26. Schoenberg SO, Rieger J, Weber CH, et al. High-spatial-resolution MR angiography of renal arteries with integrated parallel acquisitions: comparison with digital subtraction angiography and US. Radiology. 2005;235:687–698
  27. Prince MR, Meaney JF. Expanding role of MR angiography in clinical practice. Eur Radiol. 2006;16(Suppl 2):B3–B8
  28. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology. 2001;218:651–657
  29. Dong Q, Schoenberg SO, Carlos RC, et al. Diagnosis of renal vascular disease with MR angiography. Radiographics. 1999;19:1535–1554
  30. Grenier N, Basseau F, Ries M, et al. Functional MRI of the kidney. Abdom Imaging. 2003;28:164–175
  31. Zhang HL, Schoenberg SO, Resnick LM, et al. Diagnosis of renal artery stenosis: combining gadolinimum-enhanced three-dimensional magnetic resonance angiography with functional magnetic resonance pulse sequences. Am J Hypertens. 2003;16:1079–1082
  32. Blum U, Krumme B, Flugel P, et al. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med. 1997;336:459–465
  33. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991;5:491–499
  34. Chuter TA, Parodi JC, Lawrence-Brown M. Management of abdominal aortic aneurysm: a decade of progress. J Endovasc Ther. 2004;11(Suppl 2):II82–II95
  35. May J, White GH, Yu W, et al. Concurrent comparison of endoluminal versus open repair in the treatment of abdominal aortic aneurysms: analysis of 303 patients by life table method. J Vasc Surg. 1998;27:213–220discussion 220–1
  36. Blum U, Langer M, Spillner G, et al. Abdominal aortic aneurysms: preliminary technical and clinical results with transfemoral placement of endovascular self-expanding stent-grafts. Radiology. 1996;198:25–31
  37. Becquemin JP, Allaire E, Desgranges P, et al. Delayed complications following EVAR. Tech Vasc Interv Radiol. 2005;8:30–40
  38. Hellinger JC. Endovascular repair of thoracic and abdominal aortic aneurysms: pre- and postprocedural imaging. Tech Vasc Interv Radiol. 2005;8:2–15
  39. Thurnher SA, Dorffner R, Thurnher MM, et al. Evaluation of abdominal aortic aneurysm for stent-graft placement: comparison of gadolinium-enhanced MR angiography versus helical CT angiography and digital subtraction angiography. Radiology. 1997;205:341–352
  40. Engellau L, Albrechtsson U, Dahlstrom N, et al. Measurements before endovascular repair of abdominal aortic aneurysms. MR imaging with MRA vs. angiography and CT. Acta Radiol. 2003;44:177–184
  41. Lutz AM, Willmann JK, Pfammatter T, et al. Evaluation of aortoiliac aneurysm before endovascular repair: comparison of contrast-enhanced magnetic resonance angiography with multidetector row computed tomographic angiography with an automated analysis software tool. J Vasc Surg. 2003;37:619–627
  42. Wicky S, Fan CM, Geller SC, et al. MR angiography of endoleak with inconclusive concomitant CT angiography. AJR Am J Roentgenol. 2003;181:736–738
  43. Haulon S, Lions C, McFadden EP, et al. Prospective evaluation of magnetic resonance imaging after endovascular treatment of infrarenal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001;22:62–69
  44. Tombach B, Heindel W. Value of 1.0-M gadolinium chelates: review of preclinical and clinical data on gadobutrol. Eur Radiol. 2002;12:1550–1556
  45. Hiatt MD, Rubin GD. Surveillance for endoleaks: how to detect all of them. Semin Vasc Surg. 2004;17:268–278
  46. Thomsen HS. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur Radiol. 2006;16:2619–2621
  47. Thomsen HS, Marckmann P, Logager VB. Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?. Acta Radiol. 2007;48:593–596
  48. Kanal E, Broome DR, Martin DR, et al. Response to the FDA's May 23, 2007, Nephrogenic systemic fibrosis update. Radiology. 2008;246:11–14
  49. Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology. 2007;245:68–75
  50. Broome DR, Girguis MS, Baron PW, et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol. 2007;188:86–92

PII: S0846-5371(09)00105-3

doi: 10.1016/j.carj.2009.05.008

Canadian Association of Radiologists Journal
Volume 60, Issue 3 , Pages 133-142 , June 2009

Article Tools

* Image Usage & Resolution